RECRUITING

Remote Evaluation of MIND Diet

Description

The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.

Conditions

Multiple SclerosisCognitive ChangeNutrition, Healthy
Talk to us

Related Conditions:

Multiple SclerosisCognitive ChangeNutrition, Healthy

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.

Remote Evaluation of MIND Diet

Remote Evaluation of MIND Diet

Condition
Multiple Sclerosis
Intervention / Treatment

-

Contacts and Locations

Urbana

University of Illinois Urbana-Champaign, Urbana, Illinois, United States, 61801

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Individuals aged 18-64 years old
  • 2. Self-reported diagnosis of Multiple sclerosis (MS)
  • 3. 20/20 or corrected vision
  • 4. No other neurodegenerative disease diagnosis
  • 5. Stable disease-modifying therapy (DMT) within 6 months
  • 6. Not Pregnant or lactating
  • 7. No food allergies or intolerances
  • 8. Able to consume study meals
  • 9. Not enrolled in another dietary, exercise, or medication study during the study
  • 10. Access to a computer/laptop with internet
  • 1. Individuals younger than 18 or older than 64 years old
  • 2. No self-reported diagnosis of Multiple sclerosis (MS)
  • 3. Not 20/20 or uncorrected vision
  • 4. Other neurodegenerative disease diagnosis
  • 5. Disease modifying therapy (DMT) less than 6 months
  • 6. Pregnant or lactating
  • 7. Food allergies or intolerances
  • 8. Not able to consume study meals
  • 9. Enrolled in another dietary, exercise, or medication study during the study
  • 10. No access to a computer/laptop with internet

Ages Eligible for Study

18 Years to 64 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Illinois at Urbana-Champaign,

Naiman Khan, PhD, PRINCIPAL_INVESTIGATOR, University of Illinois Urbana-Champaign

Study Record Dates

2026-12-31